Suppr超能文献

多巴胺激动剂和 NMDA 拮抗剂诱导的前脉冲抑制破坏的时程:给药方案的影响。

Time course of prepulse inhibition disruption induced by dopamine agonists and NMDA antagonists: effects of drug administration regimen.

机构信息

Department of Psychology, University of Nebraska-Lincoln, Lincoln, NE 68588-0308, USA.

出版信息

Pharmacol Biochem Behav. 2011 Sep;99(3):509-18. doi: 10.1016/j.pbb.2011.05.001. Epub 2011 May 10.

Abstract

Prepulse inhibition (PPI) of acoustic startle response is impaired in patients with schizophrenia and in animals acutely treated with dopamine agonists and NMDA antagonists. In this study, we investigated the time course of PPI disruption induced by repeated amphetamine, quinpirole, phencyclidine (PCP), and dizocilpine (MK-801) treatment. We focused on how PPI disruption development was influenced by drug administration regimens, comparing a constant versus an escalating dosing regimen. Male Sprague-Dawley rats were repeatedly treated with amphetamine (1.25-5.0 mg/kg, or constant 5.0 mg/kg, sc), PCP (0.50-2.0 mg/kg, or constant 0.5, 1.0 or 2.0 mg/kg, sc), quinpirole (0.03-0.12 mg/kg, or constant 0.12 mg/kg, sc), MK-801 (0.025-0.10 mg/kg, or constant 0.10 mg/kg, sc) or vehicle (saline) and tested for PPI once daily for 6 consecutive days. When amphetamine 5.0 mg/kg or quinpirole 0.12 mg/kg was administrated on a constant dosing schedule, both drugs disrupted PPI upon acute administration, but had no effect after repeated treatment and testing (days 2-5). However, when amphetamine 5.0 mg/kg or quinpirole 0.12 mg/kg was preceded by two lower doses in an escalating dosing regimen, both drugs still disrupted PPI on days 5 and 6 when the constant amphetamine and quinpirole had no effect. For PCP and MK-801, repeated treatment under both regimens produced a stable and persistent disruption of PPI. Startle magnitude increased progressively and dose-dependently under both regimens for all drugs except for quinpirole, which caused a decrease. These results suggest that the drug dosing schedule, rather than the absolute amount of drug that an animal receives, has a greater impact on the development of PPI-disruptive effect of dopamine agonists than NMDA antagonists. Thus, in order to mimic the emerging process of PPI deficit with dopamine agonists, an escalating dosing regimen should be used.

摘要

声发射起始反应的前脉冲抑制(PPI)在精神分裂症患者和急性给予多巴胺激动剂和 NMDA 拮抗剂的动物中受损。在这项研究中,我们研究了反复给予安非他命、喹吡罗、苯环己哌啶(PCP)和地卓西平(MK-801)治疗引起的 PPI 破坏的时程。我们专注于药物管理方案如何影响 PPI 破坏的发展,比较固定剂量方案和递增剂量方案。雄性 Sprague-Dawley 大鼠反复接受安非他命(1.25-5.0mg/kg,或固定 5.0mg/kg,sc)、PCP(0.50-2.0mg/kg,或固定 0.5、1.0 或 2.0mg/kg,sc)、喹吡罗(0.03-0.12mg/kg,或固定 0.12mg/kg,sc)、MK-801(0.025-0.10mg/kg,或固定 0.10mg/kg,sc)或载体(盐水)治疗,并每天进行一次 PPI 测试,连续 6 天。当安非他命 5.0mg/kg 或喹吡罗 0.12mg/kg 按固定剂量方案给药时,两种药物在急性给药时均破坏 PPI,但在重复治疗和测试(第 2-5 天)后没有影响。然而,当安非他命 5.0mg/kg 或喹吡罗 0.12mg/kg 在前两个较低剂量的递增剂量方案中给药时,当固定的安非他命和喹吡罗没有效果时,两种药物仍在第 5 和第 6 天破坏 PPI。对于 PCP 和 MK-801,两种方案下的重复治疗均导致 PPI 稳定且持续中断。除了喹吡罗,所有药物的惊跳幅度都逐渐增加且呈剂量依赖性,喹吡罗则导致惊跳幅度下降。这些结果表明,药物给药方案而不是动物接受的药物绝对量,对多巴胺激动剂而非 NMDA 拮抗剂的 PPI 破坏作用的发展影响更大。因此,为了模拟多巴胺激动剂引起的 PPI 缺陷的出现过程,应使用递增剂量方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验